Clinical Trial Update: Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update from Novartis evaluating the effects of current Alzheimer's disease medications on brain chemical levels. The study is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Novartis | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED